Drug intelligence / Profile preview

GnRH antagonist + methyltestosterone

Development stage
Preclinical
Lead developer
Merck KGaA
Modality
Small Molecules
Administration
Oral, Subcutaneous
01

Overview

GnRH antagonist + methyltestosterone is a combination therapy that works through complementary mechanisms. GnRH antagonists competitively bind to GnRH receptors in the pituitary gland, preventing native GnRH from binding and thereby suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to decreased testosterone production. Methyltestosterone is an anabolic steroid hormone that supplements testosterone levels. This combination allows for hormonal suppression while maintaining sufficient testosterone levels to prevent side effects like decreased libido. The combination has been studied as a potential male contraceptive approach and for treating certain hormone-dependent conditions.

02

Targets

GnRHR (Gonadotropin-releasing hormone receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on GnRH antagonist + methyltestosterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GnRH antagonist + methyltestosterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call